WO2026017907 - CONTROL OF A CRISPR CAS REACTION
National phase entry is expected:
Publication Number
WO/2026/017907
Publication Date
22.01.2026
International Application No.
PCT/EP2025/070791
International Filing Date
21.07.2025
Title **
[English]
CONTROL OF A CRISPR CAS REACTION
[French]
COMMANDE D'UNE RÉACTION CRISPR CAS
Applicants **
ETH ZURICH
Inventors
DEMELLO, Andrew
AROSIO, Paolo
PAGANINI, Carolina
RICHARDS, Daniel
LESINSKI, Jacob
Priority Data
24189631.5
19.07.2024
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2580 | |
| EPO | Filing, Examination, Granting | 11070 | |
| Japan | Filing, Examination, Granting | 2215 | |
| South Korea | Filing, Examination, Granting | 2192 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
22,797
Contact Us
Abstract[English]
The invention pertains to a method for controlling a reaction of a CRISPR Cas effector protein with a target, an associated CRISPR Cas effector protein and associated uses for detection, optionally detection of a nucleic acid in a biological sample or in a sample derived from a biological material.[French]
L'invention concerne un procédé de commande d'une réaction d'une protéine effectrice CRISPR Cas avec une cible, une protéine effectrice CRISPR Cas associée et des utilisations associées pour la détection, éventuellement la détection d'un acide nucléique dans un échantillon biologique ou dans un échantillon dérivé d'un matériau biologique.